Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Dong-E-E-Jiao Co.,Ltd.
  6. News
  7. Sector news
    000423   CNE0000006Y9

DONG-E-E-JIAO CO.,LTD.

(000423)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2023-01-31
43.90 CNY   -0.20%
01/30Dong-E-E-Jiao Expects Up to 810 Million Yuan in 2022 Profit; Shares Rise 4%
MT
01/30Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022
CI
2022Dong-E-E-Jiao's January-September Profit Increases; Stock Rises 4%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Alternative Medicine
02/03Yiling Pharma Gets Regulatory Nod for Traditional Chinese Medicine
MT
02/03Buchang Pharmaceuticals Plans to Set Up Headquarters at Shijiazhuang International Biom..
MT
02/03Yiling Pharma's Antibiotic Passes Consistency Test
MT
02/01Buchang Pharmaceuticals Unit Gets Production License from Chinese Provincial Drug Regul..
MT
01/20Shijiazhuang Yiling’s Depression Drug Included in China’s Medical Insurance..
MT
01/08Yiling Pharma’s Traditional Chinese Medicine Added to Government's Recommended Dr..
MT
01/03Gloom and boom: Fund managers' top picks for 2023
RE
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Appoints Mao Weiwen as Non..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Cessation of Won..
CI
2022Chinese Shares End Year With Modest Gains; Two Shenzhen Debutants Post Mixed Results
MT
2022China stocks jump on easing COVID curbs
RE
2022China stocks rise on further eased COVID rules
RE
2022Shijiazhuang Yiling Pharma Secures Regulatory Nod For Traditional Chinese Medicine Tria..
MT
2022Yiling Pharma Denies Claims That COVID-19 Drug May Cause Liver Injury
MT
2022Shijiazhuang Yiling Pharmaceutical's Anti-Respiratory Disease Drug Enters Singaporean M..
MT
2022China stocks retreat on concerns of surging COVID cases
RE
2022China stocks retreat on concerns of rising COVID cases
RE
2022Investors bet on greed and fear as China loosens COVID grip
RE
2022Tianjin Pharmaceutical Da Ren Tang Group Corporatio..
CI
2022Yiling to Boost Production of Traditional Herbal Medicine for Flu; Shares Rally 7%
MT
2022Chinese rush to stock up antigen kits, medicines as COVID prevention curbs ease
RE
2022Shandong Buchang Pharmaceuticals Unit Gets Registration Certificate for Anti-Lung Disea..
MT
2022Buchang Pharmaceutical's Lung Detoxifying Drug Gets Extension of Validity to 24 Months
MT
2022China, HK stocks drop on COVID outbreaks, geopolitical risks
RE
2022China, HK stocks drop on COVID outbreaks, geopolitical risks
RE
2022Yiling Pharma Seeks Clinical Trial of Chinese Medicine Against Colds; Shares Rally 5%
MT
2022Tianjin Pharmaceutical Profit Jumps 31% in Q3 on Higher Revenue
MT
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results f..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Resignation of Z..
CI
2022Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Mont..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E..
CI
2022Buchang Pharmaceuticals Cleared to Launch Clinical Trial of Cancer Drug
MT
2022Tianjin Pharmaceutical Da Ren Tang Group Corporatio..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited agreed to acquire addition..
CI
2022Tianjin Pharmaceutical to Buy Controlling Stake in NewScen Coast Bio for $6 Million
MT
2022NewScen Coast Bio-Pharmaceutical Co., Ltd announced that it expects to receive CNY 43.2..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year End..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
2022Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results f..
CI
2022Changrui Biotechnology Co., Ltd. announced that it expects to receive CNY 64 million in..
CI
2022Tianjin Zhongxin Board OKs Use of $52 Million Placement Proceeds
MT
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces Final Dividend on Share A for 20..
CI
2022Tianjin Pharmaceutical Da Ren Tang Group Corporatio..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Final Dividend for..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for ..
CI
2022Yiling Pharmaceutical's Q1 Profit Tumbles 28% as Sales Plummet
MT
2022Tianjin Zhongxin Pharmaceutical Posts Lower Profit in January-March
MT
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year ..
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Zhang Yu as Chief P..
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter..
CI
2022Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
2022Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quart..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021
CI
2022Yiling Pharma's Shares Sink on Doubts Over COVID-19 Drug Efficacy
MT
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Recommends to Declare Divide..
CI
2022Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2022Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year End..
CI
2021Sichuan Tianrunyuan Enterprise Management Co., Ltd., Pu Xiaoping, Wang Baocai, Li Weiju..
CI
2021Shunten International Limited Enters into Cooperation Framework Agreement with Shijiazh..
CI
2021Tianjin Zhongxin Pharmaceutical Elects New Chairman; Shares Slip 3%
MT
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Approves Election of Ms. Zha..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Mr. Xing Jianhua as..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Ms. Zhang Mingrui a..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Resignation of Tan..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. and Shandong Buchang Shenzhou Pharmaceutical..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction
CI
2021Tianjin Zhong Xin Pharmaceutical : Zhongxin Board OKs U..
MT
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Approves Appointment of Guo ..
CI
2021Sichuan Tianrunyuan Enterprise Management Co., Ltd., Pu Xiaoping, Wang Baocai, Li Weiju..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year End..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Approves Executive Appointme..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Resignation of Mr...
CI
2021HS Bio Sdn. Bhd. Enters into MOU with Shijiazhuang Yiling Pharmaceutical Co., Ltd
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces 2020 Final Distribution Plan to ..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Final Dividend in ..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Dividend on A Shares for the Y..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Cash Dividend for 2020
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Announces Appointment of Ind..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Appoints Qiang Zhiyuan as Le..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Dividend for the Year 2020
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Recommends Dividend for the ..
CI
2021Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Reports Earnings Results for..
CI
2021Tianjin Pharmacy Holdings Co., Ltd. completed the acquisition of 31.02% stake in Tianji..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quart..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 202..
CI
Upcoming event on DONG-E-E-JIAO CO.,LTD.